Feedback / Questions
RGT-61159 - Rgenta Therap
https://www.globenewswire.com/news-release/2025/06/12/3098260/0/en/Rgenta-Therapeutics-Presents-Preclinical-Data-from-Lead-Program-RGT-61159-a-Potent-and-Selective-Small-Molecule-Inhibitor-of-MYB-RNA-Supporting-its-Application-in-the-Treatment-of-.html
Jun 12, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next